Torrent Pharma recalls select batches of Semalix injection after Dr. Reddy's notice

Torrent Pharmaceuticals on Thursday said it is implementing a voluntary recall as a precautionary measure only for select batches of Semalix injection disposable pens used for treatment of diabetes.

"Patient safety is of paramount importance to us. There is no risk to patients already on this treatment because of this recall. Further, all other SKUs of Semaglutide being sold by Torrent including the oral formulation remain completely unaffected," according to a stock exchange filing by the company.

The recall is limited to select batches of Semalix Injection 2 mg and 4 mg manufactured by DRL. All other Semalix and Sembolic products, including tablets manufactured by Torrent, the 8 mg Semalix injection manufactured by MSN Laboratories, and the Sembolic reusable injection manufactured by Zydus Lifesciences, remain unaffected and continue to be available.